Date	Chamber	Action
8/11/2017	House	Public Act . . . . . . . . . 100-0065

Statutes Amended In Order of Appearance

410 ILCS 620/3.14

from Ch. 56 1/2, par. 503.14

Synopsis As Introduced
Amends the Illinois Food, Drug and Cosmetic Act. Deletes provisions requiring manufacturers to provide the Director of Public Health with a notification containing product technical bioequivalence information no later than 60 days prior to specified generic drug product substitution. Effective immediately.

Actions 

Date	Chamber	Action
2/8/2017	House	Filed with the Clerk by Rep. Norine K. Hammond
2/8/2017	House	First Reading
2/8/2017	House	Referred to Rules Committee
2/22/2017	House	Assigned to Human Services Committee
3/8/2017	House	Do Pass / Short Debate Human Services Committee; 012-000-000
3/8/2017	House	Placed on Calendar 2nd Reading - Short Debate
3/9/2017	House	Second Reading - Short Debate
3/9/2017	House	Placed on Calendar Order of 3rd Reading - Short Debate
3/15/2017	House	Third Reading - Short Debate - Passed 110-000-000
3/15/2017	House	Added Chief Co-Sponsor Rep. Patricia R. Bellock
3/16/2017	Senate	Arrive in Senate
3/16/2017	Senate	Placed on Calendar Order of First Reading
3/16/2017	Senate	Chief Senate Sponsor Sen. Jil Tracy
3/16/2017	Senate	First Reading
3/16/2017	Senate	Referred to Assignments
4/25/2017	Senate	Assigned to Public Health
5/3/2017	Senate	Do Pass Public Health; 006-000-000
5/3/2017	Senate	Placed on Calendar Order of 2nd Reading May 4, 2017
5/12/2017	Senate	Second Reading
5/12/2017	Senate	Placed on Calendar Order of 3rd Reading May 15, 2017
5/19/2017	Senate	Third Reading - Passed; 053-000-000
5/19/2017	House	Passed Both Houses
6/16/2017	House	Sent to the Governor
8/11/2017	House	Governor Approved
8/11/2017	House	Effective Date August 11, 2017
8/11/2017	House	Public Act . . . . . . . . . 100-0065

Back To Top